Xilio Therapeutics (XLO) Treasury Shares (2020 - 2026)
Xilio Therapeutics (XLO) posted Treasury Shares of $15914.0 for Q1 2026, down 33.32% sequentially from $23866.0 in Q4 2025, and down 95.24% YoY from $334125.0 in Q1 2025.
Xilio Therapeutics (XLO) Treasury Shares (2020 - 2026) Analysis & Trends
Xilio Therapeutics has reported Treasury Shares for 7 years, with the latest figure at $15914.0 in Q1 2026.
- Quarterly Treasury Shares fell 95.24% year-over-year to $15914.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15914.0 (down 95.24% YoY) and the FY2025 annual result came in at $23866.0, down 24.99% from the prior year.
- Treasury Shares declined to $15914.0 in Q1 2026 per XLO's latest filing, from $23866.0 in the prior quarter.
- Over five years, Treasury Shares peaked at $481500.0 in Q1 2024 and troughed at $5617.0 in Q4 2023.
- A 5-year average of $164831.1 and a median of $64458.0 in 2022 frame the typical range for Treasury Shares.
- The sharpest annual moves came in 2022 and 2024: Treasury Shares tumbled 99.91% in 2022, then soared 3307.53% in 2024.
- Over 5 years, Treasury Shares stood at $46160.0 in 2022, then slumped by 87.83% to $5617.0 in 2023, then jumped by 466.46% to $31818.0 in 2024, then declined by 24.99% to $23866.0 in 2025, then tumbled by 33.32% to $15914.0 in 2026.
- According to Business Quant data, Treasury Shares over the past three periods registered $15914.0, $23866.0, and $334125.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 2.72 Mn |
| 10 | Xilio Therapeutics | 178.33 Mn | 42.29 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12,824.00 |
| Jun 30, 2026 | 12,824.00 |
| Mar 31, 2026 | 15,914.00 |
| Mar 31, 2026 | 15,914.00 |
| Dec 31, 2025 | 23,866.00 |
| Dec 31, 2025 | 23,866.00 |
| Sep 30, 2025 | 334,125.00 |
| Sep 30, 2025 | 334,125.00 |
| Jun 30, 2025 | 334,125.00 |
| Jun 30, 2025 | 334,125.00 |
| Mar 31, 2025 | 334,125.00 |
| Mar 31, 2025 | 334,125.00 |
| Dec 31, 2024 | 31,818.00 |
| Dec 31, 2024 | 31,818.00 |
| Sep 30, 2024 | 445,500.00 |
| Sep 30, 2024 | 445,500.00 |
| Jun 30, 2024 | 445,500.00 |
| Jun 30, 2024 | 445,500.00 |
| Mar 31, 2024 | 481,500.00 |
| Mar 31, 2024 | 481,500.00 |